Boston, United States
In 2012, Lightstone Ventures' establishment was spearheaded by the General Partners and other vital members of Advanced Technology Ventures (ATV) and Morgenthaler's life science teams. The intention was to seize the potential returns on investing in pioneering life science companies, given the favorable conditions prevailing then.
52
Total Investments
29
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Finance, Financial Services +1
Funding Stage
Pre Seed +4
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Lightstone Ventures
Recent Investments (52)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jul 2026 | |
| Series C | •••••• | May 2026 | |
| Series A | •••••• | Sep 2025 | |
| Series B | •••••• | Aug 2025 | |
| Series C | •••••• | Apr 2025 | |
•••• ••••
|
Series B | •••••• | Apr 2024 |
|
•••• ••••
|
Series A | •••••• | Feb 2024 |
|
•••• ••••
|
Post Ipo Equity | •••••• | Oct 2023 |
|
•••• ••••
|
Private Equity Round | •••••• | Sep 2023 |
|
•••• ••••
|
Series A | •••••• | Jun 2023 |
Latest News
Alchemab lands £25m from British Business Bank in record life sciences bet
Thenextweb · Jul 09, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
